BRIEF published on 02/03/2025 at 12:05, 1 year 3 months ago Guerbet confie à NATIXIS ODDO BHF le mandat de son contrat de liquidité Euronext Paris NATIXIS ODDO BHF Contrat De Liquidité Guerbet Marchés Financiers
BRIEF published on 02/03/2025 at 12:05, 1 year 3 months ago Guerbet Appoints NATIXIS ODDO BHF for Liquidity Contract Euronext Paris Liquidity Contract NATIXIS ODDO BHF Guerbet Financial Markets
PRESS RELEASE published on 02/03/2025 at 12:00, 1 year 3 months ago GUERBET : Mise en oeuvre d’un nouveau Contrat de Liquidité avec NATIXIS-ODDO BHF Guerbet annonce la mise en œuvre d'un nouveau Contrat de Liquidité avec NATIXIS-ODDO BHF pour ses actions ordinaires sur Euronext Paris Euronext Paris Contrat De Liquidité AMF Guerbet NATIXIS-ODDO BHF
PRESS RELEASE published on 02/03/2025 at 12:00, 1 year 3 months ago GUERBET : Implementation of a Liquidity Contract with NATIXIS ODDO BHF Guerbet ends current liquidity contract and appoints NATIXIS and ODDO BHF for a new liquidity contract compliant with AMF guidelines, aiming to improve shares trading on Euronext Paris market Liquidity Contract Natixis ODDO BHF Guerbet Shares Trading
BRIEF published on 01/31/2025 at 17:50, 1 year 3 months ago Guerbet annonce son agenda financier 2025 Résultats Financiers Agenda Financier Guerbet Imagerie Médicale 2025
BRIEF published on 01/31/2025 at 17:50, 1 year 3 months ago Guerbet Announces 2025 Financial Agenda Financial Results Financial Agenda Guerbet Medical Imaging 2025
PRESS RELEASE published on 01/31/2025 at 17:45, 1 year 3 months ago Correction: GUERBET : Financial agenda for 2025 Guerbet announces its financial agenda for 2025 including revenue updates and shareholder meeting schedule Financial Agenda Guerbet Shareholder Meeting 2025 Revenue Updates
BRIEF published on 10/30/2024 at 15:57, 1 year 6 months ago Nouveaux chiffres sur les actions et droits de vote de Guerbet en septembre 2024 Capital Droits De Vote Actions AMF Guerbet
BRIEF published on 10/30/2024 at 15:57, 1 year 6 months ago New figures on Guerbet shares and voting rights in September 2024 Voting Rights Capital Actions AMF Guerbet
PRESS RELEASE published on 10/30/2024 at 15:52, 1 year 6 months ago GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2024 Déclaration relative au nombre de droits de vote et d'actions composant le capital de la société publiée conformément aux réglementations AMF Déclaration Droits De Vote Actions Capital De La Société Réglementations AMF
Published on 05/23/2026 at 19:45, 12 hours 9 minutes ago Golden Minerals Announces Closing of Equity Financing
Published on 05/23/2026 at 03:15, 1 day 4 hours ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 1 day 4 hours ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 1 day 5 hours ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 1 day 5 hours ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/24/2026 at 05:55, 1 hour 59 minutes ago The 26th CIFIT to Open in Xiamen This September, Preceded by Successful Guangzhou Roadshow
Published on 05/24/2026 at 05:35, 2 hours 19 minutes ago CGTN: Xizang at 75: Development and culture create a 'miracle on Earth'
Published on 05/23/2026 at 16:30, 15 hours 24 minutes ago HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 15 hours 57 minutes ago EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 1 day 9 hours ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 19:35, 1 day 12 hours ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 1 day 13 hours ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 1 day 13 hours ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 19 hours ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 19 hours ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
